• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童-图尔科特-普格评分和营养评估能否预测肝硬化患者的生存率:一项纵向研究。

Do Child-Turcotte-Pugh and nutritional assessments predict survival in cirrhosis: A longitudinal study.

作者信息

Carteri Randhall B, Marroni Claudio A, Ferreira Luis F, Pinto Letícia P, Czermainski Juliana, Tovo Cristiane V, Fernandes Sabrina A

机构信息

Department of Nutrition, Centro Universitário CESUCA, Cachoeirinha 94935-630, Brazil.

Postgraduate in Hepatology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre 90050-170, Brazil.

出版信息

World J Hepatol. 2025 Jan 27;17(1):99183. doi: 10.4254/wjh.v17.i1.99183.

DOI:10.4254/wjh.v17.i1.99183
PMID:39871909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11736485/
Abstract

BACKGROUND

Cirrhotic patients face heightened energy demands, leading to rapid glycogen depletion, protein degradation, oxidative stress, and inflammation, which drive disease progression and complications. These disruptions cause cellular damage and parenchymal changes, resulting in vascular alterations, portal hypertension, and liver dysfunction, significantly affecting patient prognosis.

AIM

To analyze the association between Child-Turcotte-Pugh (CTP) scores and different nutritional indicators with survival in a 15-year follow-up cohort.

METHODS

This was a retrospective cohort study with 129 cirrhotic patients of both sexes aged > 18 years. Diagnosis of cirrhosis was made by liver biopsy. The first year of data collection was 2007, and data regarding outcomes were collected in 2023. Data were gathered from medical records, and grouped by different methods, including CTP, handgrip strength, and triceps skinfold cutoffs. The prognostic values for mortality were assessed using Kaplan-Meier curves and multivariate binary logistic regression models.

RESULTS

The coefficient for CTP was the only statistically significant variable (Wald = 5.193, = 0.023). This suggests that with a negative change in CTP classification score, the odds of survival decrease 52.6%. The other evaluated variables did not significantly predict survival outcomes in the model. Kaplan-Meier survival curves also indicated that CTP classification was the only significant predictor.

CONCLUSION

Although different classifications showed specific differences in stratification, only CTP showed significant predictive potential. CTP score remains a simple and effective predictive tool for cirrhotic patients even after longer follow-up.

摘要

背景

肝硬化患者面临更高的能量需求,导致糖原迅速消耗、蛋白质降解、氧化应激和炎症,这些因素推动疾病进展和并发症的发生。这些紊乱会导致细胞损伤和实质改变,进而引起血管改变、门静脉高压和肝功能障碍,显著影响患者预后。

目的

分析在一个15年随访队列中,Child-Turcotte-Pugh(CTP)评分和不同营养指标与生存率之间的关联。

方法

这是一项回顾性队列研究,纳入了129名年龄大于18岁的男女肝硬化患者。通过肝活检确诊肝硬化。数据收集的第一年为2007年,结局数据于2023年收集。数据从医疗记录中获取,并按不同方法分组,包括CTP、握力和肱三头肌皮褶厚度临界值。使用Kaplan-Meier曲线和多变量二元逻辑回归模型评估死亡率的预后价值。

结果

CTP系数是唯一具有统计学意义的变量(Wald = 5.193,P = 0.023)。这表明CTP分类评分出现负向变化时,生存几率降低52.6%。模型中其他评估变量未显著预测生存结局。Kaplan-Meier生存曲线也表明CTP分类是唯一显著的预测因素。

结论

尽管不同分类在分层方面存在特定差异,但只有CTP显示出显著的预测潜力。即使经过更长时间的随访,CTP评分仍然是肝硬化患者简单有效的预测工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82e8/11736485/adf448d09b13/99183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82e8/11736485/adf448d09b13/99183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82e8/11736485/adf448d09b13/99183-g001.jpg

相似文献

1
Do Child-Turcotte-Pugh and nutritional assessments predict survival in cirrhosis: A longitudinal study.儿童-图尔科特-普格评分和营养评估能否预测肝硬化患者的生存率:一项纵向研究。
World J Hepatol. 2025 Jan 27;17(1):99183. doi: 10.4254/wjh.v17.i1.99183.
2
Does adding variceal status to the Child-Turcotte-Pugh score improve its performance in predicting mortality in cirrhosis?将静脉曲张状态纳入Child-Turcotte-Pugh评分是否能提高其预测肝硬化死亡率的效能?
Medicine (Baltimore). 2016 Sep;95(38):e4884. doi: 10.1097/MD.0000000000004884.
3
Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database.一种从国家电子医疗数据库估算Child-Turcotte-Pugh评分的算法的开发与性能
Clin Gastroenterol Hepatol. 2015 Dec;13(13):2333-41.e1-6. doi: 10.1016/j.cgh.2015.07.010. Epub 2015 Jul 15.
4
A Novel Predictor Compared to the Model for End-Stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) Scores for Predicting 30-Day Mortality in Patients With Liver Cirrhosis.一种新型预测指标与终末期肝病模型(MELD)及Child-Turcotte-Pugh(CTP)评分在预测肝硬化患者30天死亡率方面的比较
Cureus. 2025 Mar 30;17(3):e81446. doi: 10.7759/cureus.81446. eCollection 2025 Mar.
5
Predictive value of insulin-like growth factor 1-Child-Turcotte-Pugh score for mortality in patients with decompensated cirrhosis.胰岛素样生长因子 1-Child-Turcotte-Pugh 评分对失代偿性肝硬化患者死亡率的预测价值。
Clin Chim Acta. 2020 Jun;505:141-147. doi: 10.1016/j.cca.2020.02.031. Epub 2020 Feb 28.
6
Evaluation of creatinine-modified Child Pugh score for predicting short-term prognosis of patients with decompensated cirrhosis of liver as compare to original child Pugh score.与原始Child Pugh评分相比,评估肌酐修正的Child Pugh评分对失代偿期肝硬化患者短期预后的预测价值。
J Ayub Med Coll Abbottabad. 2009 Apr-Jun;21(2):64-7.
7
Neutrophil to Lymphocyte Ratio (NLR) and its Correlation with Child Turcotte Pugh (CTP) Score in Prediciting Severity of Decompensated Liver Cirrhosis.中性粒细胞与淋巴细胞比值(NLR)及其与 Child Turcotte Pugh(CTP)评分在预测失代偿期肝硬化严重程度中的相关性。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
8
Recalibrating the Child-Turcotte-Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis.重新校准Child-Turcotte-Pugh评分以改善肝硬化患者无移植生存期的预测
Dig Dis Sci. 2016 Nov;61(11):3309-3320. doi: 10.1007/s10620-016-4239-6. Epub 2016 Jul 12.
9
Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?纳入血清肌酐值能否改善Child-Turcotte-Pugh评分,并在肝硬化患者的短期预后评估中对终末期肝病模型评分的预后价值提出挑战?
Liver Int. 2004 Oct;24(5):465-70. doi: 10.1111/j.1478-3231.2004.0949.x.
10
Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.预测广泛肝病患者的死亡率——对终末期肝病模型(MELD)、Child-Turcotte-Pugh(CTP)评分以及肌酐修正CTP评分的评估
J Clin Exp Hepatol. 2011 Dec;1(3):161-8. doi: 10.1016/S0973-6883(11)60233-8. Epub 2012 Jan 2.

引用本文的文献

1
Importance of comprehensive nutritional assessment in predicting survival in cirrhosis.综合营养评估在预测肝硬化患者生存率中的重要性。
World J Hepatol. 2025 May 27;17(5):106606. doi: 10.4254/wjh.v17.i5.106606.
2
Hepatic cirrhosis and decompensation: Key indicators for predicting mortality risk.肝硬化及其失代偿:预测死亡风险的关键指标。
World J Hepatol. 2025 Mar 27;17(3):104580. doi: 10.4254/wjh.v17.i3.104580.

本文引用的文献

1
Mid-arm muscle circumference cutoff points in patients with cirrhosis: Low muscle mass related to malnutrition predicts mortality.肝硬化患者的上臂中部肌肉围度截断值:与营养不良相关的低肌肉量预测死亡率。
Nutrition. 2024 Sep;125:112471. doi: 10.1016/j.nut.2024.112471. Epub 2024 Apr 23.
2
Role of the phase angle in the prognosis of the cirrhotic patient: 15 years of follow-up.相位角在肝硬化患者预后中的作用:15年随访研究
World J Methodol. 2023 Sep 20;13(4):238-247. doi: 10.5662/wjm.v13.i4.238.
3
Body Composition Analysis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease.
代谢功能障碍相关脂肪性肝病患者的身体成分分析。
Nutrients. 2023 Sep 6;15(18):3878. doi: 10.3390/nu15183878.
4
Global epidemiology of cirrhosis - aetiology, trends and predictions.全球肝硬化的流行病学:病因、趋势和预测。
Nat Rev Gastroenterol Hepatol. 2023 Jun;20(6):388-398. doi: 10.1038/s41575-023-00759-2. Epub 2023 Mar 28.
5
Non-alcoholic fatty liver disease: the pathologist's perspective.非酒精性脂肪性肝病:病理学家的视角。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S302-S318. doi: 10.3350/cmh.2022.0329. Epub 2022 Nov 15.
6
Malnutrition in Patients with Liver Cirrhosis.肝硬化患者的营养不良。
Nutrients. 2021 Feb 7;13(2):540. doi: 10.3390/nu13020540.
7
Phase Angle From Bioelectrical Impedance for the Assessment of Sarcopenia in Cirrhosis With or Without Ascites.基于生物电阻抗的相位角评估肝硬化伴或不伴腹水患者的肌肉减少症。
Clin Gastroenterol Hepatol. 2021 Sep;19(9):1941-1949.e2. doi: 10.1016/j.cgh.2020.08.066. Epub 2020 Sep 2.
8
Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice?肝硬化患者的营养评估、肌肉减少症和衰弱:临床实践中我们应该使用哪些工具?
Nutrients. 2020 Jan 9;12(1):186. doi: 10.3390/nu12010186.
9
Prognostic value of risk scoring systems for cirrhotic patients with variceal bleeding.肝硬化静脉曲张出血患者风险评分系统的预后价值。
World J Gastroenterol. 2019 Dec 7;25(45):6668-6680. doi: 10.3748/wjg.v25.i45.6668.
10
Increasing Economic Burden in Hospitalized Patients With Cirrhosis: Analysis of a National Database.肝硬化住院患者经济负担增加:国家数据库分析。
Clin Transl Gastroenterol. 2019 Jul;10(7):e00062. doi: 10.14309/ctg.0000000000000062.